SRINIVAS AKKARAJU

Profile

First Name

: SRINIVAS

Middle Name

:

Last Name

: AKKARAJU

Related Companies
Titles
Company Name
Related People
DIRECTOR
SEATTLE GENETICS INC /WA
FELIX BAKER, FRANKLIN M. BERGER, ERIC L. DOBMEIER, DAVID W. GRYSKA, DANIEL F. HOTH, MARK E. LIPPMAN, JOHN P. MCLAUGHLIN, THOMAS C. REYNOLDS, MORRIS Z. ROSENBERG, CLAY B. SIEGALL, TODD E. SIMPSON, DANIEL G. WELCH
DIRECTOR
PRESIDIO PHARMACEUTICALS, INC.
H. THOMAS ANDERTON, FELIX BAKER, NAT BROWN, NATHANIEL BROWN, RICH COLONNO, RICHARD COLONNO, RODNEY FERGUSON, KENNETH GALBRAITH, OMAR HAFFAR, DAVID JOBES, SCOTT LESSING, LEPING LI, KELVIN NEU, JACK OBIJESKI, JOHN OBIJESKI, JOHN F. OBIJESKI, DANIEL PEREZ, H. DANIEL PEREZ, LEO REDMOND, ERIC RUBY, PAMELA VIG, ROBERT WILLIAMSON
DIRECTOR
VERSARTIS, INC.
JOSHUA BRUMM, JEFFREY CLELAND, FRANCESCO DE RUBERTIS, LEONARD SCOTT DOVE, MICHAEL DYBBS, FREDRIC N. ESHELMAN, ROBERT B. GELLER, AMATO GIACCIA, PETER T.C. HO, JOHN A. HOHNECKER, RUDY HOWARD, EDMON JENNINGS, KEVIN JOHNSON, SIGURD C. KIRK, SHAHZAD MALIK, GAIL MCINTYRE, MICHAEL W. ROGERS, VOLKER SCHELLENBERGER, JAY SHEPARD, WILLEM STEMMER, ANTHONY SUN, PAUL WESTBERG, ERIC ZHANG
DIRECTOR
PRINCIPIA BIOPHARMA INC.
SRINI AKKARAJU, M.D., PH.D., MARTIN BABLER, DANIEL BECKER, ELIOT CHARLES, ALAN COLOWICK, MICHAEL DYBBS, SIMEON GEORGE, SIMEON J. GEORGE, M.D., RICHARD A. MILLER, M.D., LEWIS J. SHUSTER, LEWIS J. SHUSTER, PETER THOMPSON, PETER THOMPSON, M.D., NASSIM USMAN, NASSIM USMAN, M.D.
DIRECTOR
SYROS PHARMACEUTICALS, INC.
NOUBAR B. AFEYAN, MARK ALLES, STEPHANE BANCEL, JAMES E. BRADNER, CONELY CHEE, DOUGLAS COLE, JORGE CONDE, DEBORAH DUNSIRE, SUE GAIL ECKHARDT, MARSHA FANUCCI, JOSEPH FERRA, JR., JASON HAAS, AMIR NASHAT, ROBERT NELSEN, ANDREW OH, ERIC OLSON, SANJ PATEL, GERALD QUIRK, DAVID ROTH, VICKI SATO, PHILIP SHARP, PHILLIP SHARP, NANCY SIMONIAN, JEREMY SPRINGHORN, KRISTIN STEPHENS, TIMOTHY C. TYSON, HARRY WILCOX III, HARRY W. WILCOX III, PETER WIRTH, RICHARD A. YOUNG
DIRECTOR
SAMSARA BIOCAPITAL, L.P.
MICHAEL DYBBS, N/A N/A SAMSARA BIOCAPITAL GP, LLC
DIRECTOR
565 SPV I, L.P.
N/A 565 SPV GP I, LLC, MICHAEL DYBBS
DIRECTOR
TENTARIX BIOTHERAPEUTICS, LP
THOMAS F. BUMOL, JEREL DAVIS, STEPHEN DEMAREST, CORY FREEDLAND, PAUL GRAYSON, PAUL KANG, MARGARET KAROW, ALYSSA LOCHBAUM, DONALD J. SANTEL, ALLYSON TIGHE
DIRECTOR
CHINOOK THERAPEUTICS U.S., INC.
SRINI AKKARAJU, JEREMY CALDWELL, JEREL DAVIS, ERIC DOBMEIER, PAUL EISENBERG, TOM FROLICH, ALAN GLICKLICH, SAM HALL, ANDREW KING, PRESTON KLASSEN
DIRECTOR
MINERALYS THERAPEUTICS, INC.
ALEXANDER ASAM, JON CONGLETON, DEREK DIROCCO, ADAM LEVY, OLIVIER LITZKA, TAKESHI TAKAHASHI, BRIAN TAYLOR SLINGSBY
DIRECTOR
ORSOBIO, INC.
EDWARD FLEMING, CORY FREEDLAND, GANGADHARA GANAPATI, MUZAMMIL MANSURI, EVAN RACHLIN, MANI SUBRAMANIAN, MATTHEW YOUNG
DIRECTOR
VTV THERAPEUTICS INC.
FAHED AL MARZOOQI, LARRY ALTSTIEL, RAYMOND CHEONG, STEVEN COHEN, JOHN FRY, JOHN A. FRY, KEITH HARRIS, STEPHEN HOLCOMBE, RUDY HOWARD, JEFFREY KINDLER, HERSH KOZLOV, PAUL MEISTER, RICHARD NELSON, CRAIG PARKER, PAUL SAVAS, PAUL J. SEKHRI, NOEL SPIEGEL, STEVEN TUCH, HOWARD WEINER, HOWARD L. WEINER
DIRECTOR
ALUMIS INC.
MARTIN BABLER, VIKRAM BAJAJ, JULIAN BAKER, MARK BRADLEY, ALAN COLOWICK, ALAN B. COLOWICK, JORN DRAPPA, RICHARD GASTER, DAVID M. GOLDSTEIN, ROY C. HARDIMAN, SARA KLEIN, JUNE LEE, PATRICK MACHADO, DERRICK RICHARDSON, MICHAEL ROME, JOHN R. SCHROER, SAPNA SRIVASTAVA, SAPNA B. SRIVASTAVA, JAMES TANANBAUM, JAMES B. TANANBAUM, ZHENGBIN YAO
DIRECTOR
SAMSARA OPPORTUNITY FUND, L.P.
MIRAN AHMAD, ABRAHAM BASSAN, MICHAEL DYBBS, ABRAR HUSSAIN, N/A SAMSARA OPPORTUNITY FUND GP, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-26
D
Link
HEDGE FUND 
 
 
 
2025-09-12 
2024-08-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-14 
2024-07-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-07-17 
2024-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-04 
2024-03-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-02-27 
2023-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-27 
2023-09-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-28 
2022-09-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-09-16 
2022-06-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-01 
2020-12-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-08 
2020-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-17 
2020-09-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-13 
2019-11-05
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-17 
2018-09-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-16 
2018-04-20
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-22 
2018-03-22
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-22 
2018-02-09
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-01-08 
2018-01-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-01-08 
2015-08-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-21 
2014-02-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-14 
2014-02-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-04 
2013-01-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
2013-01-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
2012-11-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-12-15 
2011-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-12-15 
2011-08-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-07-27 
2011-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-14 
2009-07-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-30 
2009-07-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-30 
2009-06-01
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-05-20